144
Views
13
CrossRef citations to date
0
Altmetric
Letter

Establishment of a one-sided ex vivo human placenta perfusion model to assess adhesion and invasion behavior of T cell leukemia cell lines

, , , &
Pages 1811-1813 | Received 25 Oct 2012, Accepted 09 Dec 2012, Published online: 18 Jan 2013

References

  • Tolar J, Neglia JP. Transplacental and other routes of cancer transmission between individuals. J Pediatr Hematol Oncol 2003;25:430–434.
  • Sato Y, Izumi Y, Minegishi K, et al. Prenatal findings in congenital leukemia: a case report. Fetal Diagn Ther 2011;29:325–330.
  • Isoda T, Ford AM, Tomizawa D, et al. Immunologically silent cancer clone transmission from mother to offspring. Proc Natl Acad Sci USA 2009;106:17882–17885.
  • Yagasaki H, Ohashi H, Ito M, et al. A novel mechanism of transplacental cancer transmission: natural killer/T-cell lymphoma in the paratesticular region is of maternal origin. Blood 2011;117: 6046–6047.
  • Mose T, Mathiesen L, Karttunen V, et al. Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris. Placenta 2012;33:433–439.
  • Heinzelmann J, Enke U, Seyfarth L, et al. Development of a human model to study homing behavior of immune cells into decidua and placental villi under ex vivo conditions. Am J Reprod Immunol 2009;61:19–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.